E3 ubiquitin ligases in ErbB receptor quantity control.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Seminars in Cell and Developmental Biology

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcdb.2010.09.006PMID 20868762PMCID PMC2991564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Geldanamycin selectively targets the nascent form of ERBB3 for degradation

  2010cited by this paper
• The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.

  2010cited by this paper
• HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy

  2010cited by this paper
• The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?

  2010cited by this paper
• Targeting the dynamic HSP90 complex in cancer

  2010cited by this paper
• Mechanisms of resistance to HER family targeting antibodies.

  2010cited by this paper
• ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

  2010cited by this paper
• Genetic determinants at the interface of cancer and neurodegenerative disease

  2010cited by this paper
• Colorectal cancer in review: the role of the EGFR pathway

  2010cited by this paper
• Post-transcriptional Mechanisms Contribute to the Suppression of the ErbB3 Negative Regulator Protein Nrdp1 in Mammary Tumors*

  2010cited by this paper
• Physiological functions of the HECT family of ubiquitin ligases

  2009cited by this paper
• Nedd4 mediates ErbB4 JM‐a/CYT–1 ICD ubiquitination and degradation in MDCK II cells

  2009cited by this paper
• Regulation of protein stability by GSK3 mediated phosphorylation

  2009cited by this paper
• The role of protease activity in ErbB biology.

  2009cited by this paper
• Endocytosis and intracellular trafficking of ErbBs.

  2009cited by this paper
• Mechanisms of ErbB receptor negative regulation and relevance in cancer.

  2009cited by this paper
• Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates

  2009cited by this paper
• ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.

  2009cited by this paper
• Down-Regulating Destruction: Phosphorylation Regulates the E3 Ubiquitin Ligase Nedd4-2

  2009cited by this paper
• WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer

  2009cited by this paper
• Novel anticancer targets: revisiting ERBB2 and discovering ERBB3

  2009cited by this paper
• Oncogenic EGFR Signaling Networks in Glioma

  2009cited by this paper
• Negative regulation of signaling by the EGFR family

  2008cited by this paper
• ErbB4/HER4: Role in Mammary Gland Development, Differentiation and Growth Inhibition

  2008cited by this paper
• Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective

  2008cited by this paper
• HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer

  2008cited by this paper
• Derailed endocytosis: an emerging feature of cancer

  2008cited by this paper
• The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation

  2008cited by this paper
• The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed Therapies

  2008cited by this paper
• A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.

  2008cited by this paper
• Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

  2008cited by this paper
• SPEAKER PRESENTATIONS

  2008cited by this paper
• ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer

  2008cited by this paper
• ErbB3 is required for ductal morphogenesis in the mouse mammary gland

  2008cited by this paper
• Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.

  2008cited by this paper
• Role of ErbB4 in Breast Cancer

  2008cited by this paper
• Regulation of cullin RING ligases.

  2008cited by this paper
• The epidermal growth factor receptor: from development to tumorigenesis.

  2007cited by this paper
• The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies.

  2007cited by this paper
• The neuregulin-I/ErbB signaling system in development and disease.

  2007cited by this paper
• Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.

  2007cited by this paper
• Gene copy numbers of HER family in breast cancer

  2007cited by this paper
• HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.

  2007cited by this paper
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007cited by this paper
• Role of the UPS in Liddle syndrome

  2007cited by this paper
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

  2007cited by this paper
• Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3

  2007cited by this paper
• Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1

  2007cited by this paper
• The mammalian N-end rule pathway: new insights into its components and physiological roles.

  2007cited by this paper
• HECT E3s and human disease

  2007cited by this paper
• Structure‐based mutagenesis of the substrate‐recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3

  2007cited by this paper
• FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

  2007cited by this paper
• Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

  2007cited by this paper
• Epidermal growth factor receptor targeting in cancer.

  2006cited by this paper
• Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8)*

  2006cited by this paper
• Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.

  2006cited by this paper
• Parkin and defective ubiquitination in Parkinson's disease.

  2006cited by this paper
• Modification of proteins by ubiquitin and ubiquitin-like proteins.

  2006cited by this paper
• Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

  2006cited by this paper
• Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer

  2006cited by this paper
• Cellular functions of the BRCA tumour-suppressor proteins.

  2006cited by this paper
• HSP90 and the chaperoning of cancer

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase

  2005cited by this paper
• TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases

  2005cited by this paper
• Ubiquitylation and cell signaling

  2005cited by this paper
• Regulation of cullin-based ubiquitin ligases by the Nedd8/RUB ubiquitin-like proteins.

  2004cited by this paper
• Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network

  2004cited by this paper
• A RING Finger Ubiquitin Ligase Is Protected from Autocatalyzed Ubiquitination and Degradation by Binding to Ubiquitin-specific Protease USP7*

  2004cited by this paper
• Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8

  2004cited by this paper
• The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

  2003cited by this paper
• The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

  2003cited by this paper
• Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation

  2003cited by this paper
• Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins.

  2003cited by this paper
• The ErbB receptors and their role in cancer progression.

  2003cited by this paper
• Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

  2003cited by this paper
• ErbB2 Degradation Mediated by the Co-chaperone Protein CHIP*

  2003cited by this paper
• Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation*

  2003cited by this paper
• Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu

  2002cited by this paper
• Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3

  2002cited by this paper
• An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels

  2002cited by this paper
• Hsp90: a specialized but essential protein-folding tool.

  2001cited by this paper
• Mechanisms underlying ubiquitination.

  2001cited by this paper
• Cbl: many adaptations to regulate protein tyrosine kinases

  2001cited by this paper
• γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase

  2001cited by this paper
• The Evolutionarily Conserved N-terminal Region of Cbl Is Sufficient to Enhance Down-regulation of the Epidermal Growth Factor Receptor*

  2000cited by this paper
• A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis*

  2000cited by this paper
• Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

  2000cited by this paper
• c-Cbl Is a Suppressor of the Neu Oncogene*

  2000cited by this paper
• Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

  1999cited by this paper
• Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.

  1999cited by this paper
• Expression of c-erbB3 protein in primary breast carcinomas.

  1998cited by this paper
• c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.

  1998cited by this paper
• Hormonal Regulation of Type I Receptor Tyrosine Kinase Expression in the Mammary Gland

  1997cited by this paper
• Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

  1997cited by this paper
• All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*)

  1996cited by this paper
• Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation.

  1996cited by this paper
• Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin*

  1996cited by this paper
• Involvement of the neuregulins and their receptors in cardiac and neural development.

  1996cited by this paper
• Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.

  1996cited by this paper

• Tensins in Cancer: Integration of Their Domain Functions, Context-Dependent Regulation and Biomarker Potential

  2025cites this paper
• The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein

  2022cites this paper
• Inherent Beta Cell Dysfunction Contributes to Autoimmune Susceptibility

  2021cites this paper
• The role of tensins in malignant neoplasms

  2021cites this paper
• Chaperone-assisted E3 ligase CHIP: A double agent in cancer

  2021cites this paper
• CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis Degradation

  2021cites this paper
• HER3 expression and MEK activation in non-small-cell lung carcinoma

  2021cites this paper
• HER-3 Expression and MEK Activation in Non-small Cell Lung Cancer

  2020cites this paper
• The many substrates and functions of NEDD4-1

  2019cites this paper
• The role of tetraspanin 6 in colorectal cancer

  2019cites this paper
• Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer

  2018cites this paper
• Disruption of ubiquitin mediated proteolysis is a widespread mechanism of tumorigenesis

  2018cites this paper
• BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines

  2018cites this paper
• Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7

  2018cites this paper
• Targeting protein quality control pathways in breast cancer

  2017cites this paper
• HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo

  2017cites this paper
• Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.

  2017cites this paper
• KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3‐ligase Nrdp1‐mediated degradation

  2017cites this paper
• The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation

  2016cites this paper
• The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3

  2016cites this paper
• Membrane Protein Quantity Control at the Endoplasmic Reticulum

  2016cites this paper
• Do we have enough knowledge to win the fight against ovarian cancer

  2016cites this paper
• HER3/ErbB3, an emerging cancer therapeutic target.

  2015cites this paper
• A CHIPotle in physiology and disease.

  2015cites this paper
• Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells

  2015cites this paper
• Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study

  2015cites this paper
• The Role of Tumor Suppressor Co-Chaperone CHIP/STUB1 in ERBB2-Mediated Oncogenesis

  2015cites this paper
• Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines.

  2014cites this paper
• Pharmacological Targeting of the Pseudokinase Her3

  2014cites this paper
• Ubiquitin-dependent sorting in endocytosis.

  2014cites this paper
• Regulation of ERBB3/HER3 signaling in cancer

  2014cites this paper
• Oligomerization of the Nrdp 1 E 3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB 3 Ubiquitination *

  2014cites this paper
• The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling

  2014cites this paper
• Oligomerization of the Nrdp1 E3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB3 Ubiquitination*

  2014cites this paper
• The role of the Neuregulin-1/Erbb signaling pathway in cardiac morphogenesis and remodeling

  2014cites this paper
• Post-translational regulation of the cellular levels of DAPK

  2013cites this paper
• Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.

  2013cites this paper
• Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases

  2013cites this paper
• Endoplasmic Reticulum Protein Quality Control Is Determined by Cooperative Interactions between Hsp/c70 Protein and the CHIP E3 Ligase*

  2013cites this paper
• Novel Functions of ErbB4 and NRG-1 in Development and Cancer

  2013cites this paper
• Signaling and Feedback Networks Underlying Senstivity and Resistance to Kinase Inhibitors in Oncogene Addicted Cancers

  2013cites this paper
• Interrogation of EpoR Fidelity in Myelodysplastic Syndrome Hematopoiesis and Stabilization by the Immunomodulatory Agent, Lenalidomide

  2013cites this paper
• Endoplasmic Reticulum Protein Quality Control is Determined by Cooperative Interactions Between Hsp / c 70 and the CHIP E 3 Ligase

  2013cites this paper
• Molecular mechanisms controlling endocytic downregulation of EGFR and ErbB3

  2013influential citation
• CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.

  2013cites this paper
• Hsp70 Chaperone Systems in Vesicular Trafficking

  2012cites this paper
• MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors.

  2012cites this paper
• SATB2 is a Modulator of p63α in Cancer and Development

  2011cites this paper
• Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia.

  2011cites this paper
• Quantity Control of the ErbB3 Receptor Tyrosine Kinase at the Endoplasmic Reticulum

  2011cites this paper
• EGFs and ERBBs--brief history and prospects.

  2010cites this paper